Effects of shiga toxin 2 on lethality, fetuses, delivery, and puerperal behavior in pregnant mice

Infection and Immunity

Volumn 68, Issue 4, 2000, Pages 2254-2258

  Yoshimura, Kazuaki ^a,d   Fujii, Jun ^a   Tanimoto, Akihide ^a   Yutsudo, Takashi ^b   Kashimura, Masamichi ^a   Yoshida, Shin Ichi ^c  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SHIGA TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BEHAVIOR; CHILDBIRTH; CONTROLLED STUDY; ENDOTHELIUM CELL; ESCHERICHIA COLI; FETUS DEVELOPMENT; FETUS GROWTH; LETHALITY; MATERNAL MORTALITY; MOUSE; NONHUMAN; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PUERPERIUM; VASCULAR ENDOTHELIUM;

ANIMALS; BACTERIAL TOXINS; CYTOTOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; FEMALE; FETAL DEATH; FETUS; IN SITU NICK-END LABELING; LETHAL DOSE 50; MATERNAL BEHAVIOR; MATERNAL MORTALITY; MICE; MICE, INBRED ICR; PLACENTA; PREGNANCY; PREGNANCY, ANIMAL; SHIGA TOXINS; UTERUS;

EID: 0034097450     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.4.2254-2258.2000     Document Type: Article

References (22)

1. Adachi, E., H. Tanaka, N. Toyoda, and T. Takeda. 1999. Detection of bactericidal antibody in the breast milk of a mother infected with enterohemorrhagic Escherichia coli O157:H7. Kansenshogaku Zasshi. 73:451-456.
2. Buendia, A. J., J. Sánchez, M. C. Martinez, P. Cámara, J. A. Navarro, A. Rodolakis, and J. Salinas. 1998. Kinetics of infection and effects on placental cell populations in a murine model of Chlamydia psittaci-induced abortion. Infect. Immun. 66:2128-2134.
3. Fidel, P. L., Jr., R. Romero, N. Wolf, J. Cutright, M. Ramirez, H. Araneda, and D. B. Cotton. 1994. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am. J. Obstet. Gynecol. 170:1467-1475.
4. Gibbs, R. S., and P. Duff. 1991. Progress in pathogenesis and management of clinical intraamniotic infection. Am. J. Obstet. Gynecol. 164:1317-1326.
5. Hillier, S. L., J. Martius, M. Krohn, N. Kiviat, K. K. Holmes, and D. A. Eschenbach. 1988. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N. Engl. J. Med. 319:972-978.
6. Inward, C. D., J. Williams, I. Chant, J. Crocker, D. V. Milford, P. E. Rose, and C. M. Taylor. 1995. Verocytotoxin-1 induces apoptosis in vero cells. J. Infect. 30:213-218.
7. Karmali, M. A. 1989. Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2:15-38.
8. Karmali, M. A., M. Petric, C. Lim, P. C. Fleming, G. S. Arbus, and H. Lior. 1985. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J. Infect. Dis. 151:775-782.
9. Karmali, M. A., B. T. Steele, M. Petric, and C. Lim. 1983. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1:619-620.
10. Kiyokawa, N., T. Taguchi, T. Mori, H. Uchida, N. Sato, T. Takeda, and J. Fujimoto. 1998. Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2. J. Infect. Dis. 178:178-184.
11. Laviola, G., S. Petruzzi, J. Rankin, and E. Alleva. 1994. Induction of maternal behavior by mouse neonates: influence of dam parity and prenatal oxazepam exposure. Pharmacol. Biochem. Behav. 49:871-876.
12. Lingwood, C. A. 1994. Verotoxin-binding in human renal sections. Nephron 66:21-28.
13. Lingwood, C. A., H. Law, S. Richardson, M. Petric, J. L. Brunton, S. De Grandis, and M. Karmali. 1987. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem. 262:8834-8839.
14. McLauchlin, J. 1990. Human listeriosis in Britain, 1967-85, a summary of 722 cases. 2. Listeriosis in non-pregnant individuals, a changing pattern of infection and seasonal incidence. Epidemiol. Infect. 104:191-201.
15. Morrison, D. M., D. L. Tyrrell, and L. D. Jewell. 1986. Colonic biopsy in verotoxin-induced hemorrhagic colitis and thrombotic thrombocytopenic purpura (TTP). Am. J. Clin. Pathol. 86:108-112.
16. Ostroff, S. M., J. M. Kobayashi, and J. H. Lewis. 1989. Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. JAMA 262:355-359.
17. Riley, L. W., R. S. Remis, S. D. Helgerson, H. B. McGee, J. G. Wells, B. R. Davis, R. J. Hebert, E. S. Olcott, L. M. Johnson, N. T. Hargrett, P. A. Blake, and M. L. Cohen. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685.
18. Scotland, S. M., G. A. Willshaw, H. R. Smith, and B. Rowe. 1987. Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2. Epidemiol. Infect. 99:613-624.
19. Silver, R. M., S. S. Edwin, M. S. Trautman, D. L. Simmons, D. W. Branch, D. J. Dudley, and M. D. Mitchell. 1995. Bacterial lipopolysaccharide-mediated fetal death. Production of a newly recognized form of inducible cyclooxygenase (COX-2) in murine decidua in response to lipopolysaccharide. J. Clin. Investig. 95:725-731.
20. Tesh, V. L., J. E. Samuel, L. P. Perera, J. B. Sharefkin, and A. D. O'Brien. 1991. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J. Infect. Dis. 164:344-352.
21. Thomas, A., H. Chart, T. Cheasty, H. R. Smith, J. A. Frost, and B. Rowe. 1993. Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989-91. Epidemiol. Infect. 110:591-600.
22. Yutsudo, T., N. Nakabayashi, T. Hirayama, and Y. Takeda. 1987. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb. Pathog. 3:21-30.